| pubmed-article:1575007 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1575007 | lifeskim:mentions | umls-concept:C0026769 | lld:lifeskim |
| pubmed-article:1575007 | lifeskim:mentions | umls-concept:C0231170 | lld:lifeskim |
| pubmed-article:1575007 | lifeskim:mentions | umls-concept:C0239307 | lld:lifeskim |
| pubmed-article:1575007 | lifeskim:mentions | umls-concept:C1514474 | lld:lifeskim |
| pubmed-article:1575007 | lifeskim:mentions | umls-concept:C1096776 | lld:lifeskim |
| pubmed-article:1575007 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:1575007 | pubmed:dateCreated | 1992-6-4 | lld:pubmed |
| pubmed-article:1575007 | pubmed:abstractText | The effects of initial clinical variables on short-term prognosis are analyzed in a cross-sectional study of 574 multiple sclerosis patients from 7 centers in 5 European countries. Patients with a primary progressive course had a 2.3 higher mean disability score (EDSS) than the primary remittent group after a mean duration of disease of 6.6 years. High age at onset was associated with a primary progressive course, and was also related to increased risk of a rapid shift to a secondary progressive course. Among the remittent patients without a secondary progressive course a high age at onset was significantly correlated to a higher disability score. In the whole remittent group the presence of pyramidal and cerebellar symptoms at onset predicted both a high disability score and a rapid shift to a secondary progression, while the effect was reverse for sensory and visual symptoms. No difference between the sexes was found. | lld:pubmed |
| pubmed-article:1575007 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1575007 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1575007 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1575007 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1575007 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:1575007 | pubmed:issn | 0001-6314 | lld:pubmed |
| pubmed-article:1575007 | pubmed:author | pubmed-author:PoserSS | lld:pubmed |
| pubmed-article:1575007 | pubmed:author | pubmed-author:MinderhoudJ... | lld:pubmed |
| pubmed-article:1575007 | pubmed:author | pubmed-author:FernándezOO | lld:pubmed |
| pubmed-article:1575007 | pubmed:author | pubmed-author:PálffyGG | lld:pubmed |
| pubmed-article:1575007 | pubmed:author | pubmed-author:NylandHH | lld:pubmed |
| pubmed-article:1575007 | pubmed:author | pubmed-author:AarliJ AJA | lld:pubmed |
| pubmed-article:1575007 | pubmed:author | pubmed-author:LauenOO | lld:pubmed |
| pubmed-article:1575007 | pubmed:author | pubmed-author:RiiseTT | lld:pubmed |
| pubmed-article:1575007 | pubmed:author | pubmed-author:GrønningMM | lld:pubmed |
| pubmed-article:1575007 | pubmed:author | pubmed-author:MidgardRR | lld:pubmed |
| pubmed-article:1575007 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1575007 | pubmed:volume | 85 | lld:pubmed |
| pubmed-article:1575007 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1575007 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1575007 | pubmed:pagination | 212-8 | lld:pubmed |
| pubmed-article:1575007 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1575007 | pubmed:meshHeading | pubmed-meshheading:1575007-... | lld:pubmed |
| pubmed-article:1575007 | pubmed:meshHeading | pubmed-meshheading:1575007-... | lld:pubmed |
| pubmed-article:1575007 | pubmed:meshHeading | pubmed-meshheading:1575007-... | lld:pubmed |
| pubmed-article:1575007 | pubmed:meshHeading | pubmed-meshheading:1575007-... | lld:pubmed |
| pubmed-article:1575007 | pubmed:meshHeading | pubmed-meshheading:1575007-... | lld:pubmed |
| pubmed-article:1575007 | pubmed:meshHeading | pubmed-meshheading:1575007-... | lld:pubmed |
| pubmed-article:1575007 | pubmed:meshHeading | pubmed-meshheading:1575007-... | lld:pubmed |
| pubmed-article:1575007 | pubmed:meshHeading | pubmed-meshheading:1575007-... | lld:pubmed |
| pubmed-article:1575007 | pubmed:meshHeading | pubmed-meshheading:1575007-... | lld:pubmed |
| pubmed-article:1575007 | pubmed:meshHeading | pubmed-meshheading:1575007-... | lld:pubmed |
| pubmed-article:1575007 | pubmed:meshHeading | pubmed-meshheading:1575007-... | lld:pubmed |
| pubmed-article:1575007 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1575007 | pubmed:articleTitle | Early prognostic factors for disability in multiple sclerosis, a European multicenter study. | lld:pubmed |
| pubmed-article:1575007 | pubmed:affiliation | Department of Neurology, University of Bergen, Norway. | lld:pubmed |
| pubmed-article:1575007 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1575007 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:1575007 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:1575007 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1575007 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1575007 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1575007 | lld:pubmed |
